These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31193493)

  • 1. Chemokines in hyperthyroidism.
    Ferrari SM; Ruffilli I; Elia G; Ragusa F; Paparo SR; Patrizio A; Mazzi V; Antonelli A; Fallahi P
    J Clin Transl Endocrinol; 2019 Jun; 16():100196. PubMed ID: 31193493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases.
    Antonelli A; Ferrari SM; Giuggioli D; Ferrannini E; Ferri C; Fallahi P
    Autoimmun Rev; 2014 Mar; 13(3):272-80. PubMed ID: 24189283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokines in thyroid autoimmunity.
    Ferrari SM; Paparo SR; Ragusa F; Elia G; Mazzi V; Patrizio A; Ghionzoli M; Varricchi G; Centanni M; Ulisse S; Antonelli A; Fallahi P
    Best Pract Res Clin Endocrinol Metab; 2023 Mar; 37(2):101773. PubMed ID: 36907786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Th1 chemokine MIG in Graves' Disease: a narrative review of the literature.
    Giusti C
    Clin Ter; 2019; 170(4):e285-e290. PubMed ID: 31304517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting chemokine (C-X-C motif) receptor 3 in thyroid autoimmunity.
    Fallahi P; Ferrari SM; Corrado A; Giuggioli D; Ferri C; Antonelli A
    Recent Pat Endocr Metab Immune Drug Discov; 2014; 8(2):95-101. PubMed ID: 24953644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Therapies for Thyroid Autoimmune Diseases.
    Fallahi P; Ferrari SM; Elia G; Nasini F; Colaci M; Giuggioli D; Vita R; Benvenga S; Ferri C; Antonelli A
    Expert Rev Clin Pharmacol; 2016 Jun; 9(6):853-61. PubMed ID: 26900630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune thyroid disorders.
    Antonelli A; Ferrari SM; Corrado A; Di Domenicantonio A; Fallahi P
    Autoimmun Rev; 2015 Feb; 14(2):174-80. PubMed ID: 25461470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Th1 Chemokines in Autoimmune Endocrine Disorders.
    Fallahi P; Ferrari SM; Ragusa F; Ruffilli I; Elia G; Paparo SR; Antonelli A
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31863667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graves' disease: Clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy.
    Antonelli A; Fallahi P; Elia G; Ragusa F; Paparo SR; Ruffilli I; Patrizio A; Gonnella D; Giusti C; Virili C; Centanni M; Shoenfeld Y; Ferrari SM
    Best Pract Res Clin Endocrinol Metab; 2020 Jan; 34(1):101388. PubMed ID: 32059832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Th1 chemokine MIG in Graves' ophthalmopathy.
    Gonnella D
    Clin Ter; 2019; 170(5):e368-e372. PubMed ID: 31612195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease.
    Romagnani P; Rotondi M; Lazzeri E; Lasagni L; Francalanci M; Buonamano A; Milani S; Vitti P; Chiovato L; Tonacchera M; Bellastella A; Serio M
    Am J Pathol; 2002 Jul; 161(1):195-206. PubMed ID: 12107104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of Fas-mediated apoptosis of human thyroid epithelial cells by IgG from patients with Graves' disease (GD) and idiopathic myxoedema.
    Kawakami A; Eguchi K; Matsuoka N; Tsuboi M; Urayama S; Kawabe Y; Tahara K; Ishikawa N; Ito K; Nagataki S
    Clin Exp Immunol; 1997 Dec; 110(3):434-9. PubMed ID: 9409648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor α agonists modulate Th1 and Th2 chemokine secretion in normal thyrocytes and Graves' disease.
    Antonelli A; Ferrari SM; Frascerra S; Corrado A; Pupilli C; Bernini G; Benvenga S; Ferrannini E; Fallahi P
    Exp Cell Res; 2011 Jul; 317(11):1527-33. PubMed ID: 21565188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role for interferon-gamma inducible chemokines in endocrine autoimmunity: an expanding field.
    Rotondi M; Lazzeri E; Romagnani P; Serio M
    J Endocrinol Invest; 2003 Feb; 26(2):177-80. PubMed ID: 12739748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL9 and CXCL11 chemokines modulation by peroxisome proliferator-activated receptor-alpha agonists secretion in Graves' and normal thyrocytes.
    Antonelli A; Ferrari SM; Frascerra S; Pupilli C; Mancusi C; Metelli MR; Orlando C; Ferrannini E; Fallahi P
    J Clin Endocrinol Metab; 2010 Dec; 95(12):E413-20. PubMed ID: 20810571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential modulation of CXCL8 versus CXCL10, by cytokines, PPAR-gamma, or PPAR-alpha agonists, in primary cells from Graves' disease and ophthalmopathy.
    Ferrari SM; Ragusa F; Paparo SR; Nasini F; Nardi M; Franceschini SS; Fallahi P; Antonelli A
    Autoimmun Rev; 2019 Jul; 18(7):673-678. PubMed ID: 31059842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monokine induced by interferon gamma (IFNgamma) (CXCL9) and IFNgamma inducible T-cell alpha-chemoattractant (CXCL11) involvement in Graves' disease and ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists.
    Antonelli A; Ferrari SM; Fallahi P; Frascerra S; Santini E; Franceschini SS; Ferrannini E
    J Clin Endocrinol Metab; 2009 May; 94(5):1803-9. PubMed ID: 19276231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Th1, Th2, and Th17 Cytokine Involvement in Thyroid Associated Ophthalmopathy.
    Shen J; Li Z; Li W; Ge Y; Xie M; Lv M; Fan Y; Chen Z; Zhao D; Han Y
    Dis Markers; 2015; 2015():609593. PubMed ID: 26089587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iodine-131 given for therapeutic purposes modulates differently interferon-gamma-inducible alpha-chemokine CXCL10 serum levels in patients with active Graves' disease or toxic nodular goiter.
    Antonelli A; Rotondi M; Fallahi P; Grosso M; Boni G; Ferrari SM; Romagnani P; Serio M; Mariani G; Ferrannini E
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1485-90. PubMed ID: 17244787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating chemokines in patients with autoimmune thyroid diseases.
    Domberg J; Liu C; Papewalis C; Pfleger C; Xu K; Willenberg HS; Hermsen D; Scherbaum WA; Schloot NC; Schott M
    Horm Metab Res; 2008 Jun; 40(6):416-21. PubMed ID: 18415893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.